203 related articles for article (PubMed ID: 34368624)
1. Adverse Events Following COVISHIELD Vaccination Among Adult Population in Bangladesh.
Khalil MM; Mahbub-Uz-Zaman K; Hossain AS; Ahmed F; Chowdhury MFK; Khan ST; Miah MSA; Khaleque N; Kibria MG; Ahmed F; Khan AM
SN Compr Clin Med; 2021; 3(11):2207-2213. PubMed ID: 34368624
[TBL] [Abstract][Full Text] [Related]
2. Determinants of associated events following AZD1222 (Covishield) vaccination in a high-risk population in Nepal.
Poudel KM; Shah N; Prakash M; Deo SK; Bhandari S; Poudel TR
BMC Infect Dis; 2022 May; 22(1):422. PubMed ID: 35505278
[TBL] [Abstract][Full Text] [Related]
3. Incidence of Early Adverse Events Following Covishield (ChAdOx1 nCoV-19) Vaccination: A Prospective Study.
Velhal GD; Kamath YV; Agrawal AS; Vora DS; Dwivedi VR
Indian J Community Med; 2022; 47(4):613-617. PubMed ID: 36742958
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of COVID-19 vaccine reactogenicity among Bangladeshi physicians.
Majumder MAA; Lutfor AB; Rabbi AMF; Alam ABMM; Rahman M; Saha N; Campbell MH; Haque M; Nessa K; Khondoker MU; Das TR; Rahman S; Jahan F; Mashreky SR; Wahab A; Siddiqui MTH; Hinkson-Lacorbiniere K; Ivy R; Islam R; Haider Y; Omar E; Ahmed SMM; Reza AMS; Daud AKM; Choudhury MUA; Hossain MA; Pappu AM; Jahan N; Razzaque MS
FASEB Bioadv; 2022 Jun; 4(6):379-390. PubMed ID: 35601057
[TBL] [Abstract][Full Text] [Related]
5. Compliance with diphtheria, tetanus, and pertussis immunisation in Bangladesh: factors identifying high risk groups.
Zeitlyn S; Rahman AK; Nielsen BH; Gomes M; Kofoed PE; Mahalanabis D
BMJ; 1992 Mar; 304(6827):606-9. PubMed ID: 1559089
[TBL] [Abstract][Full Text] [Related]
6. Side Effects Following Administration of the First Dose of Oxford-AstraZeneca's Covishield Vaccine in Bangladesh: A Cross-Sectional Study.
Jahan N; Rahman FI; Saha P; Ether SA; Roknuzzaman A; Sarker R; Kalam KT; Haq K; Nyeen J; Himi HZ; Hossain MN; Chowdhury MH; Uddin MM; Alam NH
Infect Dis Rep; 2021 Oct; 13(4):888-901. PubMed ID: 34698203
[TBL] [Abstract][Full Text] [Related]
7. A Retrospective Cross-Sectional Study Assessing Self-Reported Adverse Events following Immunization (AEFI) of the COVID-19 Vaccine in Bangladesh.
Sultana A; Shahriar S; Tahsin MR; Mim SR; Fatema KR; Saha A; Yesmin F; Bahar NB; Samodder M; Mamun MAH; Aknur Rahman M; Ferdousy S; Akter T; Aktar F; Kuddus MR; Rahman MM; Sarker MMR; Büyüker SM; Chowdhury JA; Chowdhury AA; Kabir S; Hossain MA; Amran MS
Vaccines (Basel); 2021 Sep; 9(10):. PubMed ID: 34696198
[TBL] [Abstract][Full Text] [Related]
8. Adverse effects after first and second dose of covishield and covaxin: A longitudinal study.
Mittal A; Jain B; Varshney AM; Garg G; Sachan D; Singh RB
J Family Med Prim Care; 2022 Nov; 11(11):7339-7345. PubMed ID: 36993127
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and determinants of adverse events following ChAdOx1 nCoV-19 vaccination (COVISHIELD) - A retrospective cohort study among healthcare workers in central Karnataka, India.
Davalagi SB; Nayak VP; Ghose A; Marakatti SS; Kasturi ES; Maganahalli AS
J Family Med Prim Care; 2023 Nov; 12(11):2869-2874. PubMed ID: 38186765
[TBL] [Abstract][Full Text] [Related]
10. Smallpox vaccination and adverse reactions. Guidance for clinicians.
Cono J; Casey CG; Bell DM;
MMWR Recomm Rep; 2003 Feb; 52(RR-4):1-28. PubMed ID: 12617510
[TBL] [Abstract][Full Text] [Related]
11. Tracking Side Effects of the COVID-19 Vaccine in Mymensingh District of Bangladesh.
Khan MK; Ferdous J; Akhter S; Esha AM; Islam M
Mymensingh Med J; 2022 Jan; 31(1):1-9. PubMed ID: 34999672
[TBL] [Abstract][Full Text] [Related]
12. Safety Monitoring after the BNT162b2 COVID-19 Vaccine among Adults Aged 75 Years or Older.
Choi YY; Kim MK; Kwon HC; Kim GH
J Korean Med Sci; 2021 Nov; 36(45):e318. PubMed ID: 34811980
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of severe adverse events among health professionals after receiving the first dose of the ChAdOx1 nCoV-19 coronavirus vaccine (Covishield) in Togo, March 2021.
Konu YR; Gbeasor-Komlanvi FA; Yerima M; Sadio AJ; Tchankoni MK; Zida-Compaore WIC; Nayo-Apetsianyi J; Afanvi KA; Agoro S; Salou M; Landoh DE; Nyansa AB; Boko E; Mijiyawa M; Ekouevi DK
Arch Public Health; 2021 Nov; 79(1):207. PubMed ID: 34819146
[TBL] [Abstract][Full Text] [Related]
14. One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?
Lopez AS; Guris D; Zimmerman L; Gladden L; Moore T; Haselow DT; Loparev VN; Schmid DS; Jumaan AO; Snow SL
Pediatrics; 2006 Jun; 117(6):e1070-7. PubMed ID: 16740809
[TBL] [Abstract][Full Text] [Related]
15. Safety and tolerability of the novel 2019 coronavirus disease (COVID-19) vaccines among people with epilepsy (PwE): A cross-sectional study.
Massoud F; Ahmad SF; Hassan AM; Alexander KJ; Al-Hashel J; Arabi M
Seizure; 2021 Nov; 92():2-9. PubMed ID: 34391030
[TBL] [Abstract][Full Text] [Related]
16. mRNA COVID-19 Vaccine Reactogenicity among Healthcare Workers: Results from an Active Survey in a Pediatric Hospital from Bucharest, January-February 2021.
Crăciun MD; Nițescu GV; Golumbeanu M; Tănase AA; Pițigoi D; Săndulescu O; Crăciun P; Enciu BG; Bălănescu RN; Ulici A
Vaccines (Basel); 2022 May; 10(6):. PubMed ID: 35746444
[TBL] [Abstract][Full Text] [Related]
17. Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC).
Wharton M; Strikas RA; Harpaz R; Rotz LD; Schwartz B; Casey CG; Pearson ML; Anderson LJ; ;
MMWR Recomm Rep; 2003 Apr; 52(RR-7):1-16. PubMed ID: 12710832
[TBL] [Abstract][Full Text] [Related]
18. Adverse events following the first dose of Covishield (ChAdOx1 nCoV-19) vaccination among health workers in selected districts of central and western Nepal: A cross-sectional study.
Subedi P; Yadav GK; Paudel B; Regmi A; Pyakurel P
PLoS One; 2021; 16(12):e0260638. PubMed ID: 34932553
[TBL] [Abstract][Full Text] [Related]
19. Coverage and cost of a large oral cholera vaccination program in a high-risk cholera endemic urban population in Dhaka, Bangladesh.
Khan IA; Saha A; Chowdhury F; Khan AI; Uddin MJ; Begum YA; Riaz BK; Islam S; Ali M; Luby SP; Clemens JD; Cravioto A; Qadri F
Vaccine; 2013 Dec; 31(51):6058-64. PubMed ID: 24161413
[TBL] [Abstract][Full Text] [Related]
20. Post-vaccination Symptoms of Covishield Vaccine among Frontline Workers of a Tertiary Care Center in Pathanamthitta District.
Dev SS; Vargese SS; Mamachan S; Varghese AV; Mathew E
Indian J Community Med; 2023; 48(1):61-64. PubMed ID: 37082400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
